314 related articles for article (PubMed ID: 31685017)
1. Whole-genome sequencing of ocular Chlamydia trachomatis isolates from Gadarif State, Sudan.
Alkhidir AAI; Holland MJ; Elhag WI; Williams CA; Breuer J; Elemam AE; El Hussain KMK; Ournasseir MEH; Pickering H
Parasit Vectors; 2019 Nov; 12(1):518. PubMed ID: 31685017
[TBL] [Abstract][Full Text] [Related]
2. Population-based analysis of ocular Chlamydia trachomatis in trachoma-endemic West African communities identifies genomic markers of disease severity.
Last AR; Pickering H; Roberts CH; Coll F; Phelan J; Burr SE; Cassama E; Nabicassa M; Seth-Smith HMB; Hadfield J; Cutcliffe LT; Clarke IN; Mabey DCW; Bailey RL; Clark TG; Thomson NR; Holland MJ
Genome Med; 2018 Feb; 10(1):15. PubMed ID: 29482619
[TBL] [Abstract][Full Text] [Related]
3. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
Harding-Esch EM; Holland MJ; Schémann JF; Sillah A; Sarr B; Christerson L; Pickering H; Molina-Gonzalez S; Sarr I; Andreasen AA; Jeffries D; Grundy C; Mabey DCW; Herrmann B; Bailey RL
Parasit Vectors; 2019 Oct; 12(1):497. PubMed ID: 31640755
[TBL] [Abstract][Full Text] [Related]
4. Survey, Culture, and Genome Analysis of Ocular
Feng L; Lu X; Yu Y; Wang T; Luo S; Sun Z; Duan Q; Wang N; Song L
Front Cell Infect Microbiol; 2016; 6():207. PubMed ID: 28119858
[TBL] [Abstract][Full Text] [Related]
5. Genomic insights into local-scale evolution of ocular
Ghasemian E; Faal N; Pickering H; Sillah A; Breuer J; Bailey RL; Mabey D; Holland MJ
Microb Genom; 2024 Mar; 10(3):. PubMed ID: 38445851
[TBL] [Abstract][Full Text] [Related]
6. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.
Last AR; Burr SE; Harding-Esch E; Cassama E; Nabicassa M; Roberts CH; Mabey DCW; Holland MJ; Bailey RL
Parasit Vectors; 2017 Dec; 10(1):624. PubMed ID: 29282126
[TBL] [Abstract][Full Text] [Related]
7. Unravelling Chlamydia trachomatis diversity in Amhara, Ethiopia: MLVA-ompA sequencing as a molecular typing tool for trachoma.
Harte AJ; Ghasemian E; Pickering H; Houghton J; Chernet A; Sata E; Yismaw G; Zeru T; Tadesse Z; Callahan EK; Nash SD; Holland MJ
PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012143. PubMed ID: 38662795
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia trachomatis from Australian Aboriginal people with trachoma are polyphyletic composed of multiple distinctive lineages.
Andersson P; Harris SR; Smith HMBS; Hadfield J; O'Neill C; Cutcliffe LT; Douglas FP; Asche LV; Mathews JD; Hutton SI; Sarovich DS; Tong SYC; Clarke IN; Thomson NR; Giffard PM
Nat Commun; 2016 Feb; 7():10688. PubMed ID: 26912299
[TBL] [Abstract][Full Text] [Related]
9. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
West SK; Moncada J; Munoz B; Mkocha H; Storey P; Hardick J; Gaydos CA; Quinn TC; Schachter J
J Infect Dis; 2014 Jul; 210(1):65-71. PubMed ID: 24446528
[TBL] [Abstract][Full Text] [Related]
10. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
Yang JL; Hong KC; Schachter J; Moncada J; Lekew T; House JI; Zhou Z; Neuwelt MD; Rutar T; Halfpenny C; Shah N; Whitcher JP; Lietman TM
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):90-4. PubMed ID: 18689701
[TBL] [Abstract][Full Text] [Related]
11. The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children.
Pickering H; Ramadhani AM; Massae P; Mafuru E; Malisa A; Mbuya K; Makupa W; Mtuy T; Derrick T; Houghton J; Bailey RL; Mabey DCW; Burton MJ; Holland MJ
Front Public Health; 2022; 10():1015714. PubMed ID: 36324475
[TBL] [Abstract][Full Text] [Related]
12. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
[TBL] [Abstract][Full Text] [Related]
13. Mass treatment with single-dose azithromycin for trachoma.
Solomon AW; Holland MJ; Alexander ND; Massae PA; Aguirre A; Natividad-Sancho A; Molina S; Safari S; Shao JF; Courtright P; Peeling RW; West SK; Bailey RL; Foster A; Mabey DC
N Engl J Med; 2004 Nov; 351(19):1962-71. PubMed ID: 15525721
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.
Wilson N; Goodhew B; Mkocha H; Joseph K; Bandea C; Black C; Igietseme J; Munoz B; West SK; Lammie P; Kasubi M; Martin DL
Ophthalmic Epidemiol; 2019 Feb; 26(1):1-6. PubMed ID: 30543311
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau.
Last AR; Burr SE; Weiss HA; Harding-Esch EM; Cassama E; Nabicassa M; Mabey DC; Holland MJ; Bailey RL
PLoS Negl Trop Dis; 2014 Jun; 8(6):e2900. PubMed ID: 24967629
[TBL] [Abstract][Full Text] [Related]
16. Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.
Pant BP; Bhatta RC; Chaudhary JS; Awasthi S; Mishra S; Sharma S; Cuddapah PA; Gwyn SE; Stoller NE; Martin DL; Keenan JD; Lietman TM; Gaynor BD
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004462. PubMed ID: 26871898
[TBL] [Abstract][Full Text] [Related]
17. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.
Keenan JD; Ayele B; Gebre T; Moncada J; Stoller NE; Zhou Z; Porco TC; McCulloch CE; Gaynor BD; Emerson PM; Schachter J; Lietman TM
Clin Infect Dis; 2012 Jan; 54(2):253-6. PubMed ID: 22095569
[TBL] [Abstract][Full Text] [Related]
18. Ocular Chlamydia Trachoma.
George N; Levine AC
CJEM; 2016 Sep; 18(5):401. PubMed ID: 26140694
[No Abstract] [Full Text] [Related]
19. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for ocular chlamydia after three mass azithromycin distributions.
Ayele B; Gebre T; Moncada J; House JI; Stoller NE; Zhou Z; Porco TC; Gaynor BD; Emerson PM; Schachter J; Keenan JD
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1441. PubMed ID: 22180804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
